BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
BIM
115.5
+1.49%↑
SRT3
228.3
-0.7%↓
GXI
55.3
+2.88%↑
ICAD
21.08
-0.57%↓
24h
Actual
Mínimo
119.7
Máximo
122.55
Ingresos | -142M 667M |
---|---|
Ventas | 152M 5.4B |
P/B Media del Sector | 26.27 57.333 |
BPA | 2.2 |
Rentabilidad por dividendo | 1.34 |
Margen de beneficio | 12.311 |
EBITDA | 85M 1.6B |
Recomendaciones | Comprar |
---|---|
Estimación a 12 meses | +38.83% upside |
Rentabilidad por dividendo Media del Sector | 1.34% 2.63% |
---|---|
Próximas Ganancias | 15 may 2025 |
Capitalización de Mercado | 33B 98B |
---|---|
Apertura anterior | 119.98 |
Cierre anterior | 121.4 |
By Trading Central
Confianza
Very Strong Bullish Evidence
117.55 / 120.4 Soporte y Resistencia
El rendimiento pasado no es un indicador fiable de resultados futuros.
6 mar 2025, 06:27 UTC
Merck KGaA Forecasts Earnings, Sales Growth After In-Line Results
DJ
Leer
11 feb 2025, 07:03 UTC
Germany's Merck in Talks to Buy SpringWorks Therapeutics
DJ
Leer
10 feb 2025, 16:38 UTC
SpringWorks Therapeutics Shares Rise on Report it May be Acquired
DJ
Leer
24 abr 2025, 22:51 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- Update
DJ
Leer
24 abr 2025, 20:54 UTC
Merck KGaA: No Final Decision Has Been Taken; No Legally Binding Agreement Has Been Entered Into
DJ
Leer
24 abr 2025, 20:50 UTC
Merck KGaA Confirms Late-Stage Discussions With SpringWorks Therapeutics on Potential Acquisition for About 47c a Share
DJ
Leer
24 abr 2025, 19:05 UTC
Merck KGaA Expected to Pay Close to $47 a Share for SpringWorks, Sources Say -- WSJ
DJ
Leer
24 abr 2025, 19:05 UTC
Merck KGaA, SpringWorks Deal Expected to Be Finalized as Soon as Monday, Sources Say -- WSJ
DJ
Leer
24 abr 2025, 19:05 UTC
Germany's Merck Nears Roughly $3.5 Billion Deal for SpringWorks -- WSJ
DJ
Leer
24 abr 2025, 19:05 UTC
Merck KGaA Nears Roughly $3.5 Billion Takeover of SpringWorks Therapeutics, Sources Say -- WSJ
DJ
Leer
6 mar 2025, 11:18 UTC
Impact from U.S. Tariffs Is Manageable for Merck KGaA, CEO Says -- Market Talk
DJ
Leer
6 mar 2025, 11:14 UTC
Merck KGaA's Outlook Signals Greater Transparency -- Market Talk
DJ
Leer
6 mar 2025, 08:20 UTC
Merck KGaA's Earnings Guidance Seems Soft Amid Semiconductor Uncertainty -- Market Talk
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Expects 2025 Net Sales Between EUR21.5B and EUR22.9B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Adj EPS EUR8.63
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Expects 2025 EBITDA Before One-Time Items Between EUR6.1B and EUR6.6B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 EBIT EUR3.645B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 After-Tax Profit EUR2.79B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Ebitda Before One-Time Items EUR6.07B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 EBITDA EUR5.78B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA 2024 Sales EUR21.16B
DJ
Leer
6 mar 2025, 06:00 UTC
Merck KGaA Keeps Dividend at EUR2.20
DJ
Leer
6 mar 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Sales at EUR21.14B
DJ
Leer
6 mar 2025, 06:00 UTC
Analysts Saw Merck KGaA 2024 Ebitda Before One-Time Items at EUR6.08B
DJ
Leer
11 feb 2025, 16:45 UTC
Merck's Potential Springworks Deal Unlikely to Move Needle on Earnings -- Market Talk
DJ
Leer
11 feb 2025, 10:54 UTC
Germany's Merck Potential Buy of SpringWorks Therapeutics Puts Its Strategy Into Question -- Market Talk
DJ
Leer
11 feb 2025, 10:52 UTC
German Merck's Potential Buy of SpringWorks Therapeutics Holds Profitability Risk -- Market Talk
DJ
Leer
6 ene 2025, 13:08 UTC
Merck KGaA: Transaction closed on Dec. 23, 2024
DJ
Leer
6 ene 2025, 13:07 UTC
Merck KGaA: Didn't Disclose Financial Details
DJ
Leer
6 ene 2025, 13:06 UTC
Merck KGaA: HUB's Organoid Offering Complements Merck KGaA's Cell Culture Portfolio
DJ
Leer
Cambio de precio
By TipRanks
Estimación a 12 meses
Media 166.25 EUR 38.83%
Máximo 190 EUR
Mínimo 107 EUR
De acuerdo con 9 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Merck KGaA Dist en los últimos 3 meses.
By TipRanks
Comprar
9 ratings
6
Comprar
2
Mantener
1
Vender
De acuerdo con 9 analistas que ofrecen calificaciones bursátiles a para Merck KGaA Dist en los últimos 3 meses.
By Trading Central
Corto Plazo
Very Strong Bullish Evidence
Recent bullish events outweigh bearish events.
Medio plazo
Bearish Evidence
All events are bearish.
Largo Plazo
Bearish Evidence
All events are bearish.
Gastos de venta y administración
Gastos operativos
Beneficio antes de impuestos
Ventas
Coste de ventas
Beneficio bruto de ventas
Gasto por intereses de deuda
EBITDA
Beneficio operativo
$